GSK3A and breast cancer: In summary, we have demonstrated that mitochondrially targeted iron chelators, mitoDFO and mitoDFX, upregulate NDRG1 expression and induce Thr346 phosphorylation via the GSK3α/β kinase in breast cancer cells.